KK
NRIX icon

KLP Kapitalforvaltning’s Nurix Therapeutics NRIX Stock Holding History

KLP Kapitalforvaltning’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$251K Hold
16,200
– – ﹤0.01% 1730
2025
Q4 		$307K Buy
16,200
+800
+5% +$11.5K ﹤0.01% 1672
2025
Q3 		$142K Hold
15,400
– – ﹤0.01% 1948
2025
Q2 		$175K Buy
15,400
+4,300
+39% +$46.5K ﹤0.01% 1838
2025
Q1 		$132K Hold
11,100
– – ﹤0.01% 1917
2024
Q4 		$209K Buy
+11,100
New +$254K ﹤0.01% 1803

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

KLP Kapitalforvaltning's NRIX Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Nurix Therapeutics (NRIX) position steady in Q1 2026 at 16,200 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #1730.

KLP Kapitalforvaltning first reported a position in NRIX in Q4 2024 and has held it in 6 quarters since. The position peaked at $307K in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • KLP Kapitalforvaltning held 16,200 shares of Nurix Therapeutics worth $251K as of Q1 2026.
  • KLP Kapitalforvaltning left its Nurix Therapeutics share count unchanged in Q1 2026.
  • Nurix Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1730 holding.
  • KLP Kapitalforvaltning first reported a position in Nurix Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Nurix Therapeutics position peaked at $307K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.